Skip to main content
. 2000 Oct 16;151(2):425–438. doi: 10.1083/jcb.151.2.425

Figure 2.

Figure 2

Processing of HA truncation mutants. (A) Chymotrypsin (C) or trypsin (T) treated CV-1 cells were biotinylated, lysed, immunoprecipitated with the Site A antibody, resolved by SDS-PAGE, transferred to nitrocellulose, and visualized with streptavidin-HRP. Like WT HA, all mutant HAs exhibit efficient processing. (B) CV-1 cells were metabolically labeled, treated with trypsin, lysed, immunoprecipitated with an HA-specific mAb, treated with 1 U of N-Glycosidase F for 2 h at 37°C, and resolved on 15% SDS-PAGE. The gels were dried and exposed to film. Δ2–12 HA exhibit a mobility shift indicative of a truncated HA2 subunit (HA2*).